Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07200128 · ClinicalTrials.gov registry record
A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings
A clinical trial of Severe Alopecia Areata, sponsored by Pfizer.
- Completed
- Registry status
- 123
- Enrollment target
- 1
- Study location
NCT07200128 is a study of Severe Alopecia Areata that has completed, run by Pfizer. The registered enrollment target is 123 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07200128, a study of Severe Alopecia Areata, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 123 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a secondary analysis of the Adelphi Real World Alopecia Areata II United States Disease Specific Programmes database. This database contains data from a cross-sectional study capturing linked physician and patient survey data for dermatologists who treat alopecia areata and patients diagnosed with alopecia areata in the United States. The retrospective analysis of these data will evaluate experiences of patients and dermatologists receiving/prescribing ritlecitinib for severe alopecia areata in the United States. Specifically, the study will describe characteristics of patients who received ritlecitinib for severe alopecia areata, including demographics, clinical characteristics at the time of starting ritlecitinib, and their alopecia areata-related treatment history. The study will also report dermatologist satisfaction with treatment and change in the patient's alopecia areata severity and disease activity from the start of ritlecitinib to different time points on treatment.
Conditions Studied
Interventions
- DRUG Ritlecitinib
Study Locations (1)
New York
- Pfizer - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2025-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07200128
The ClinicalTrials.gov registry entry for NCT07200128 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Severe Alopecia Areata appearing as the primary indexed condition, and to 1 intervention - of which Ritlecitinib is the first listed.
NCT07200128 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07200128 about?
NCT07200128 is a clinical study titled "A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Settings". This study is a secondary analysis of the Adelphi Real World Alopecia Areata II United States Disease Specific Programmes database. This database contains data from a cross-sectional study capturing linked physician and patient survey data for dermatologists who treat alopecia areata and patients di...
What is the current status of trial NCT07200128?
This trial is currently completed. The enrollment target is 123 participants. The study started on 2025-02-03. Estimated completion is 2025-05-30.
What conditions does trial NCT07200128 study?
This clinical trial studies the following conditions: Severe Alopecia Areata.
What interventions are being tested in trial NCT07200128?
The interventions under investigation include: Ritlecitinib (DRUG).
Who is sponsoring clinical trial NCT07200128?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07200128 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Severe Alopecia Areata
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.